119 related articles for article (PubMed ID: 37787270)
1. The adherence to the American Association for the Study of Liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survival.
Manne A; Mulekar M; Escobar D; Prodduturvar P; Fahmawi Y; Henderson P; Abdul-Rahim O; Hussain Z; Liles S; Fonseca A; Howard JH; Mneimneh W; Gilbert R; Alkharabsheh O; Pai S; White ZB; Nelson C; Khushman M
J Cancer Res Ther; 2023; 19(5):1103-1108. PubMed ID: 37787270
[TBL] [Abstract][Full Text] [Related]
2. Impact of guideline adherence on the prognosis of Barcelona clinic liver cancer stage B hepatocellular carcinoma.
Han JE; Cho HJ; Cheong JY; Lim SG; Yang MJ; Noh CK; Lee GH; Kim SS
World J Gastroenterol; 2023 Dec; 29(47):6122-6137. PubMed ID: 38186683
[TBL] [Abstract][Full Text] [Related]
3. Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study.
Farinati F; Sergio A; Baldan A; Giacomin A; Di Nolfo MA; Del Poggio P; Benvegnu L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F
BMC Cancer; 2009 Jan; 9():33. PubMed ID: 19171074
[TBL] [Abstract][Full Text] [Related]
4. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group.
Torzilli G; Belghiti J; Kokudo N; Takayama T; Capussotti L; Nuzzo G; Vauthey JN; Choti MA; De Santibanes E; Donadon M; Morenghi E; Makuuchi M
Ann Surg; 2013 May; 257(5):929-37. PubMed ID: 23426336
[TBL] [Abstract][Full Text] [Related]
5. BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group.
Farinati F; Vanin V; Giacomin A; Pozzan C; Cillo U; Vitale A; Di Nolfo AM; Del Poggio P; Benvegnu' L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F;
Liver Int; 2015 Jan; 35(1):223-31. PubMed ID: 25074434
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hepatocellular carcinoma in a tertiary Romanian center. Deviations from BCLC recommendations and influence on survival rate.
Radu P; Groza I; Iancu C; Al Hajjar N; Andreica V; Sparchez Z
J Gastrointestin Liver Dis; 2013 Sep; 22(3):291-7. PubMed ID: 24078986
[TBL] [Abstract][Full Text] [Related]
7. Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular Carcinoma.
Chen LJ; Chang YJ; Chang YJ
Oncologist; 2021 Mar; 26(3):e445-e453. PubMed ID: 32969134
[TBL] [Abstract][Full Text] [Related]
8. Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania.
Guarino M; Tortora R; de Stefano G; Coppola C; Morisco F; Salomone Megna A; Izzo F; Nardone G; Piai G; Adinolfi LE; D'Adamo G; Gaeta GB; Messina V; Francica G; De Girolamo V; Coppola N; Persico M; Di Costanzo GG;
J Gastroenterol Hepatol; 2018 May; 33(5):1123-1130. PubMed ID: 28994145
[TBL] [Abstract][Full Text] [Related]
9. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
[TBL] [Abstract][Full Text] [Related]
10. Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage.
Kikuchi L; Chagas AL; Alencar RSSM; Tani C; Diniz MA; D'Albuquerque LAC; Carrilho FJ
Clinics (Sao Paulo); 2017 Aug; 72(8):454-460. PubMed ID: 28954003
[TBL] [Abstract][Full Text] [Related]
11. Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective.
Li JW; Goh BG; Chang PE; Tan CK
World J Gastroenterol; 2017 Jun; 23(22):4054-4063. PubMed ID: 28652658
[TBL] [Abstract][Full Text] [Related]
12. Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias.
Yen YH; Cheng YF; Wang JH; Lin CC; Chen CH; Wang CC
PLoS One; 2021; 16(3):e0249194. PubMed ID: 33765059
[TBL] [Abstract][Full Text] [Related]
13. Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations.
Sangiovanni A; Triolo M; Iavarone M; Forzenigo LV; Nicolini A; Rossi G; La Mura V; Colombo M; Lampertico P
Liver Int; 2018 Sep; 38(9):1624-1634. PubMed ID: 29791968
[TBL] [Abstract][Full Text] [Related]
14. Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis.
Chen YS; Hsieh PM; Lin HY; Hung CM; Lo GH; Hsu YC; Lu IC; Lee CY; Wu TC; Yeh JH; Hsiao P; Li YC; Wang YC; Hsieh KC; Lin CW
BMC Gastroenterol; 2021 May; 21(1):220. PubMed ID: 33990184
[TBL] [Abstract][Full Text] [Related]
15. Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma.
Wang X; Wang Z; Wu L
BMC Surg; 2016 Apr; 16():22. PubMed ID: 27094483
[TBL] [Abstract][Full Text] [Related]
16. Effect of vessels that encapsulate tumor clusters (VETC) on the prognosis of different stages of hepatocellular carcinoma after hepatectomy.
Wang YY; Dong K; Wang K; Sun Y; Xing BC
Dig Liver Dis; 2023 Sep; 55(9):1288-1294. PubMed ID: 37037766
[TBL] [Abstract][Full Text] [Related]
17. Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia.
Liu YW; Yong CC; Lin CC; Wang CC; Chen CL; Cheng YF; Wang JH; Yen YH; Chen CH
J Surg Oncol; 2020 Dec; 122(8):1587-1594. PubMed ID: 32815189
[TBL] [Abstract][Full Text] [Related]
18. The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma.
Gómez-Rodríguez R; Romero-Gutiérrez M; Artaza-Varasa T; González-Frutos C; Ciampi-Dopazo JJ; de-la-Cruz-Pérez G; Sánchez-Ruano JJ
Rev Esp Enferm Dig; 2012 Jun; 104(6):298-304. PubMed ID: 22738699
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma tumour burden score to stratify prognosis after resection.
Tsilimigras DI; Moris D; Hyer JM; Bagante F; Sahara K; Moro A; Paredes AZ; Mehta R; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Sasaki K; Rodarte AI; Aucejo FN; Pawlik TM
Br J Surg; 2020 Jun; 107(7):854-864. PubMed ID: 32057105
[TBL] [Abstract][Full Text] [Related]
20. Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.
Gomaa AI; Hashim MS; Waked I
PLoS One; 2014; 9(3):e90929. PubMed ID: 24603710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
